Wahing, Emelyn .
HRN: 23-51-28 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/10/2023
CO-AMOXICLAV 625MG (TAB)
08/10/2023
08/17/2023
PO
625 Mg
BID
Nsvd
Waiting Final Action